Abbott Laboratories
NYSE:ABT
Sector
Location
Market Cap
USD 223.66 B
Share Price
USD 128.55
Avg Daily Volume
6,749,929
Change (1 day)
0.42%
Change (1 year)
22.06%
Change (YTD)
13.65%
Abbott Laboratories Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 8.95 B
Abbott Laboratories Operating Cash Flow is USD 8.95 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 25.30% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Abbott Laboratories Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 7.14 B, a -17.51% change year over year.
-
Abbott Laboratories Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 8.66 B, a -13.07% change year over year.
-
Abbott Laboratories Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 9.96 B, a 1.40% change year over year.
-
Abbott Laboratories Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 9.82 B, a 60.01% change year over year.
StockViz
Competitors
Bristol-Myers Squibb Company
USD 45.98
BMY
-0.88
-1.88%
Eli Lilly and Company
USD 760.08
LLY
-2.87
-0.38%
Medtronic plc
USD 91.64
MDT
-0.80
-0.86%
Johnson & Johnson
USD 167.26
JNJ
-0.85
-0.51%
AbbVie Inc.
USD 189.31
ABBV
-1.91
-1.00%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|